RxDoctor Payments DataLook up a doctor →

Gary Schuster, MD

Internal Medicine · Bellevue, WANPI 1053500223

Payments from drug & device makers

$15,533in general payments, 2019–2025

Across 799 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$2K
  • Pfizer$1K
  • AstraZeneca$1K
  • Biohaven Pharmaceuticals, Inc.$581
  • Novo Nordisk$572
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)95$1,922
Amgen(2 entities)84$1,668
Pfizer66$1,433
AstraZeneca60$1,229
Biohaven Pharmaceuticals, Inc.56$581
Novo Nordisk32$572
Teva Pharmaceuticals USA, Inc.27$557
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC26$545
Lilly USA, LLC27$518
Biohaven Pharmaceutical Holding Company Ltd.39$514
Astellas Pharma US Inc10$390
Novartis17$385
Takeda Pharmaceuticals U.S.A., Inc.20$375
Antares Pharma, Inc.25$374
Sanofi-aventis U.S. LLC16$361
Esperion Therapeutics, Inc.15$314
Amarin Pharma, Inc.17$268
GSK12$266
Boehringer Ingelheim11$242
Idorsia Pharmaceuticals US Inc11$228
Phathom Pharmaceuticals, Inc.9$183
Kowa Pharmaceuticals America, Inc.7$181
Exact Sciences6$181
Johnson & Johnson9$173
Regeneron Healthcare Solutions, Inc.9$158
Arbor Pharmaceuticals, Inc.7$134
Jazz Pharmaceuticals Inc.6$117
Bayer6$112
Azurity Pharmaceuticals, Inc.5$111
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$105
Abbott4$97
Genentech USA, Inc.5$88
Lundbeck LLC3$81
Corium, LLC4$81
IBSA Pharma Inc.3$66
Merck4$66
Ironwood Pharmaceuticals, Inc3$60
Impel Pharmaceuticals Inc.3$57
Aimmune Therapeutics, Inc.2$52
Eisai Inc.2$47
Vanda Pharmaceuticals Inc.2$47
Ipsen Biopharmaceuticals, Inc2$46
Bausch Health US, LLC2$45
Axsome Therapeutics, Inc.2$37
Alfasigma USA, Inc.2$36
E.r. Squibb & Sons, L.L.C.2$36
Medtronic1$32
Edwards Lifesciences1$31
Hikma Pharmaceuticals USA2$28
Ferring Pharmaceuticals Inc.2$27
Boston Scientific1$25
Linus Health, Inc.1$24
Bardy Diagnostics, Inc.1$24
GRT US Holding, Inc.1$21
Tris Pharma Inc1$21
Dexcom, Inc.1$21
Xeris Pharmaceuticals, Inc.1$21
Impulse Dynamics (USA) Inc.1$20
Halozyme Inc1$19
Shire North American Group Inc1$18

How this compares

$15,533 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington →

Medicare billing

Part B allowed, 2024
$185,504
Medicare patients
237
Services billed
3,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Bellevue

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →